INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)

A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Reply New Message

Prev Message Back To Forum Threaded View Next Message

agoracom administrator

Rank: Administrator [?]

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)

posted on Nov 04, 2021 12:00PM

We just sat down with Valeo Pharma CEO Steve Saviuk.

We discuss:

First provincial public listing for both asthma medications
Additional provincial public reimbursement coverage expected soon
85% private payer health plan coverage across Canada
All this less than 5 months after commercial launch

OUT TONIGHT

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply